
Avant Brands Reports Audited Fiscal 2025 Results with 19% Recreational Revenue Growth
Avant Brands Reports Audited Fiscal 2025 Results with 19% Recreational Revenue Growth

Avant Brands Reports Audited Fiscal 2025 Results with 19% Recreational Revenue Growth
PharmaCielo Announces 2025 Q3 Results, AGM Details
Delivra Health and Its Brands LivRelief (TM) and Dream Water (TM) Report Results for Second Quarter of Fiscal 2026
Simply Solventless Commences Restructuring Process for the Benefit of Shareholders and Stakeholders
Tilray Brands' Good Supply rolls out spring product lineup
Optimi supplies psilocybin for depression in Australia
Curaleaf Reports Fourth Quarter and Full Year 2025 Results: Domestic and International Growth Accelerate with Gross Margin Expansion
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
Cannara Announces Graduation to the Toronto Stock Exchange
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada
Trulieve Reports Fourth Quarter and Full Year 2025 Results with 60% Gross Margin and Record Cash Flow Generation
Decibel Cannabis to sell Creston property for $2.5M
Greenway loses $134,975 in fiscal Q3